1. Home
  2. MDBH vs BNR Comparison

MDBH vs BNR Comparison

Compare MDBH & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDBH
  • BNR
  • Stock Information
  • Founded
  • MDBH 1997
  • BNR 2014
  • Country
  • MDBH United States
  • BNR China
  • Employees
  • MDBH N/A
  • BNR N/A
  • Industry
  • MDBH
  • BNR Medical Specialities
  • Sector
  • MDBH
  • BNR Health Care
  • Exchange
  • MDBH Nasdaq
  • BNR Nasdaq
  • Market Cap
  • MDBH 40.5M
  • BNR 38.3M
  • IPO Year
  • MDBH 2023
  • BNR 2020
  • Fundamental
  • Price
  • MDBH $4.44
  • BNR $6.80
  • Analyst Decision
  • MDBH
  • BNR
  • Analyst Count
  • MDBH 0
  • BNR 0
  • Target Price
  • MDBH N/A
  • BNR N/A
  • AVG Volume (30 Days)
  • MDBH 3.5K
  • BNR 52.8K
  • Earning Date
  • MDBH 08-12-2025
  • BNR 08-21-2025
  • Dividend Yield
  • MDBH N/A
  • BNR N/A
  • EPS Growth
  • MDBH N/A
  • BNR N/A
  • EPS
  • MDBH 0.84
  • BNR N/A
  • Revenue
  • MDBH $3,574,131.00
  • BNR $72,112,038.00
  • Revenue This Year
  • MDBH N/A
  • BNR $136.32
  • Revenue Next Year
  • MDBH N/A
  • BNR N/A
  • P/E Ratio
  • MDBH $5.27
  • BNR N/A
  • Revenue Growth
  • MDBH N/A
  • BNR 0.53
  • 52 Week Low
  • MDBH $3.61
  • BNR $2.18
  • 52 Week High
  • MDBH $12.00
  • BNR $9.48
  • Technical
  • Relative Strength Index (RSI)
  • MDBH 50.35
  • BNR 67.23
  • Support Level
  • MDBH $3.91
  • BNR $4.47
  • Resistance Level
  • MDBH $4.71
  • BNR $9.48
  • Average True Range (ATR)
  • MDBH 0.23
  • BNR 0.74
  • MACD
  • MDBH -0.05
  • BNR 0.36
  • Stochastic Oscillator
  • MDBH 49.53
  • BNR 55.11

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: